{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:08:34Z","timestamp":1763251714491,"version":"3.45.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10517-025-06519-3","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:44:06Z","timestamp":1762267446000},"page":"507-517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cell Therapy Is a New Treatment Option to Prevent Neurodegenerative Changes and Restore Cognitive Functions in Alzheimer\u2019s Disease (Review)"],"prefix":"10.1007","volume":"179","author":[{"given":"A. D.","family":"Voronova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. K.","family":"Karsuntseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. S.","family":"Shishkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A.","family":"Fursa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Chadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. V.","family":"Shport","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. V.","family":"Stepanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. P.","family":"Chekhonin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"6","key":"6519_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166712","volume":"1869","author":"JS Bhatti","year":"2023","unstructured":"Bhatti JS, Khullar N, Mishra J, et al. Stem cells in the treatment of Alzheimer\u2019s disease \u2013 promises and pitfalls. Biochim Biophys Acta Mol Basis Dis. 2023;1869(6):166712. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166712","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"6519_CR2","doi-asserted-by":"publisher","unstructured":"Vasenina EE, Levin OS, Sonin AG. Modern trends in epidemiology of dementia and management of patients with cognitive impairment. Korsakov Journal of Neurology and Psychiatry. 2017;117(6-2):87-95. Russian. https:\/\/doi.org\/10.17116\/jnevro20171176287-95","DOI":"10.17116\/jnevro20171176287-95"},{"issue":"10","key":"6519_CR3","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry. 2021;26(10):5481-503. https:\/\/doi.org\/10.1038\/s41380-021-01249-0","journal-title":"Mol Psychiatry."},{"issue":"1","key":"6519_CR4","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, et al. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8(1):248. https:\/\/doi.org\/10.1038\/s41392-023-01484-7","journal-title":"Signal Transduct Target Ther."},{"issue":"5","key":"6519_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"1863","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2017;1863(5):1037-45. https:\/\/doi.org\/10.1016\/j.bbadis.2016.04.017","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"issue":"9","key":"6519_CR6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/alz.12528","volume":"18","author":"U Lim","year":"2022","unstructured":"Lim U, Wang S, Park SY, et al. Risk of Alzheimer\u2019s disease and related dementia by sex and race\/ethnicity: The Multiethnic Cohort Study. Alzheimers Dement. 2022;18(9):1625-34. https:\/\/doi.org\/10.1002\/alz.12528","journal-title":"Alzheimers Dement."},{"issue":"Suppl 1","key":"6519_CR7","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.3233\/JAD-220721","volume":"94","author":"X Chen","year":"2023","unstructured":"Chen X, Jiang S, Wang R, et al. Neural stem cells in the treatment of Alzheimer\u2019s disease: current status, challenges, and future prospects. J Alzheimers Dis. 2023;94(Suppl 1):S173-S186. https:\/\/doi.org\/10.3233\/JAD-220721","journal-title":"J Alzheimers Dis."},{"issue":"4","key":"6519_CR8","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.3390\/ijms22042153","volume":"22","author":"F Sivandzade","year":"2021","unstructured":"Sivandzade F, Cucullo L. Regenerative stem cell therapy for neurodegenerative diseases: an overview. Int J Mol Sci. 2021;22(4):2153. https:\/\/doi.org\/10.3390\/ijms22042153","journal-title":"Int J Mol Sci."},{"issue":"11","key":"6519_CR9","doi-asserted-by":"publisher","first-page":"9492","DOI":"10.3390\/ijms24119492","volume":"24","author":"DV Chandrashekar","year":"2023","unstructured":"Chandrashekar DV, Steinberg RA, Han D, et al. Alcohol as a modifiablerisk factor for Alzheimer\u2019s disease \u2013 evidence from experimental studies. Int J Mol Sci. 2023;24(11):9492. https:\/\/doi.org\/10.3390\/ijms24119492","journal-title":"Int J Mol Sci."},{"issue":"11","key":"6519_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.2174\/1570159X18666200528142429","volume":"18","author":"S Khan","year":"2020","unstructured":"Khan S, Barve KH, Kumar MS. Recent advancements in pathogenesis, diagnostics and treatment of Alzheimer\u2019s disease. Curr Neuropharmacol. 2020;18(11):1106-25. https:\/\/doi.org\/10.2174\/1570159X18666200528142429","journal-title":"Curr Neuropharmacol."},{"issue":"2","key":"6519_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/jpm10020026","volume":"10","author":"V D\u2019Argenio","year":"2020","unstructured":"D\u2019Argenio V, Sarnataro D. New insights into the molecular bases of familial Alzheimer\u2019s disease. J Pers Med. 2020;10(2):26. https:\/\/doi.org\/10.3390\/jpm10020026","journal-title":"J Pers Med."},{"issue":"10","key":"6519_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"MA Busche","year":"2020","unstructured":"Busche MA, Hyman BT. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease. Nat Neurosci. 2020;23(10):1183-93. https:\/\/doi.org\/10.1038\/s41593-020-0687-6","journal-title":"Nat Neurosci."},{"issue":"21","key":"6519_CR13","doi-asserted-by":"publisher","first-page":"12924","DOI":"10.3390\/ijms232112924","volume":"23","author":"U Sehar","year":"2022","unstructured":"Sehar U, Rawat P, Reddy AP, et al. Amyloid beta in aging and Alzheimer\u2019s disease. Int J Mol Sci. 2022;23(21):12924. https:\/\/doi.org\/10.3390\/ijms232112924","journal-title":"Int J Mol Sci."},{"key":"6519_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249-54. https:\/\/doi.org\/10.1038\/nature25456","journal-title":"Nature."},{"issue":"7","key":"6519_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM. Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol. 2018;14(7):399-415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol."},{"issue":"1","key":"6519_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023;20(1):165. https:\/\/doi.org\/10.1186\/s12974-023-02853-3","journal-title":"J Neuroinflammation."},{"key":"6519_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.772717","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Yao H, Liu W, et al. Microglia polarization in Alzheimer\u2019s disease: mechanisms and a potential therapeutic target. Front Aging Neurosci. 2021;13:772717. https:\/\/doi.org\/10.3389\/fnagi.2021.772717","journal-title":"Front Aging Neurosci."},{"key":"6519_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.815347","volume":"14","author":"S Guo","year":"2022","unstructured":"Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14:815347. https:\/\/doi.org\/10.3389\/fnagi.2022.815347","journal-title":"Front Aging Neurosci."},{"issue":"2","key":"6519_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s13365-013-0188-4","volume":"20","author":"Sarma J Das","year":"2014","unstructured":"Das Sarma J. Microglia-mediated neuroinflammation is an amplifier of virus-induced neuropathology. J Neurovirol. 2014;20(2):122-36. https:\/\/doi.org\/10.1007\/s13365-013-0188-4","journal-title":"J Neurovirol."},{"issue":"17","key":"6519_CR20","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/cells11172728","volume":"11","author":"G Di Benedetto","year":"2022","unstructured":"Di Benedetto G, Burgaletto C, Bellanca CM, et al. Roleof microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to Ca2+ homeostasis dysregulation. Cells. 2022;11(17):2728. https:\/\/doi.org\/10.3390\/cells11172728","journal-title":"Cells."},{"key":"6519_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.937133","volume":"15","author":"P Goel","year":"2022","unstructured":"Goel P, Chakrabarti S, Goel K, et al. Neuronal cell death mechanisms in Alzheimer\u2019s disease: An insight. Front Mol Neurosci. 2022;15:937133. https:\/\/doi.org\/10.3389\/fnmol.2022.937133","journal-title":"Front Mol Neurosci."},{"key":"6519_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2022.102575","volume":"75","author":"A Mangalmurti","year":"2022","unstructured":"Mangalmurti A, Lukens JR. How neurons die in Alzheimer\u2019s disease: Implications for neuroinflammation. Curr Opin Neurobiol. 2022;75:102575. https:\/\/doi.org\/10.1016\/j.conb.2022.102575","journal-title":"Curr Opin Neurobiol."},{"key":"6519_CR23","doi-asserted-by":"publisher","unstructured":"HollvilleE, Romero SE, Deshmukh M. Apoptotic cell death regulation in neurons. FEBS J. 2019;286(17):3276-98. https:\/\/doi.org\/10.1111\/febs.14970","DOI":"10.1111\/febs.14970"},{"issue":"1","key":"6519_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00401-024-02747-5","volume":"147","author":"S Balusu","year":"2024","unstructured":"Balusu S, De Strooper B. The necroptosis cell death pathway drives neurodegeneration in Alzheimer\u2019s disease. Acta Neuropathol. 2024;147(1):96. https:\/\/doi.org\/10.1007\/s00401-024-02747-5","journal-title":"Acta Neuropathol."},{"issue":"7","key":"6519_CR25","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","volume":"28","author":"D Moujalled","year":"2021","unstructured":"Moujalled D, Strasser A, Liddell JR. Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021;28(7):2029-44. https:\/\/doi.org\/10.1038\/s41418-021-00814-y","journal-title":"Cell Death Differ."},{"issue":"12","key":"6519_CR26","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1093\/brain\/awx243","volume":"140","author":"A Bejanin","year":"2017","unstructured":"Bejanin A, Schonhaut DR, La Joie R, et al. Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer\u2019s disease. Brain. 2017;140(12):3286-300. https:\/\/doi.org\/10.1093\/brain\/awx243","journal-title":"Brain."},{"issue":"13","key":"6519_CR27","doi-asserted-by":"publisher","first-page":"6841","DOI":"10.3390\/ijms22136841","volume":"22","author":"J Roy","year":"2021","unstructured":"Roy J, Tsui KC, Ng J, et al. Regulation of melatonin and neurotransmission in Alzheimer\u2019s disease. Int J Mol Sci. 2021;22(13):6841. https:\/\/doi.org\/10.3390\/ijms22136841","journal-title":"Int J Mol Sci."},{"issue":"3","key":"6519_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3233\/JAD-230040","volume":"92","author":"CS Atwood","year":"2023","unstructured":"Atwood CS, Perry G. Playing Russian roulette with Alzheimer\u2019s disease patients: do the cognitive benefits of lecanemab outweigh the risk of edema, stroke and encephalitis? J Alzheimers Dis. 2023;92(3):799-801. https:\/\/doi.org\/10.3233\/JAD-230040","journal-title":"J Alzheimers Dis."},{"issue":"1","key":"6519_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, et al. Recent advances in Alzheimer\u2019s disease: Mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Signal Transduct Target Ther."},{"issue":"3","key":"6519_CR30","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s12035-023-03573-8","volume":"61","author":"SK Kim","year":"2024","unstructured":"Kim SK, Lee GY, Kim SK, et al. Protective effects of repetitive transcranial magnetic stimulation against streptozotocininduced Alzheimer\u2019s disease. Mol Neurobiol. 2024;61(3):1687-703. https:\/\/doi.org\/10.1007\/s12035-023-03573-8","journal-title":"Mol Neurobiol."},{"issue":"4","key":"6519_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/biom11040543","volume":"11","author":"J Gregory","year":"2021","unstructured":"Gregory J, Vengalasetti YV, Bredesen DE, et al. Neuroprotective herbs for the management of Alzheimer\u2019s disease. Biomolecules. 2021;11(4):543. https:\/\/doi.org\/10.3390\/biom11040543","journal-title":"Biomolecules."},{"key":"6519_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102291","volume":"97","author":"AK Roghani","year":"2024","unstructured":"Roghani AK, Garcia RI, Roghani A, et al. Treating Alzheimer\u2019s disease using nanoparticle-mediated drug delivery strategies\/systems. Ageing Res Rev. 2024;97:102291. https:\/\/doi.org\/10.1016\/j.arr.2024.102291","journal-title":"Ageing Res Rev."},{"key":"6519_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/978-1-4939-7571-6_25","volume":"1727","author":"R Facchinetti","year":"2018","unstructured":"Facchinetti R, Bronzuoli MR, Scuderi C. An animal model of Alzheimer disease based on the intrahippocampal injection of amyloid \u03b2-peptide (1-42). Methods Mol Biol. 2018;1727:343-52. https:\/\/doi.org\/10.1007\/978-1-4939-7571-6_25","journal-title":"Methods Mol Biol."},{"issue":"11","key":"6519_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006320","volume":"2","author":"FM LaFerla","year":"2012","unstructured":"LaFerla FM, Green KN. Animal models of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(11):a006320. https:\/\/doi.org\/10.1101\/cshperspect.a006320","journal-title":"Cold Spring Harb Perspect Med."},{"issue":"4","key":"6519_CR35","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1007\/s10517-023-05899-8","volume":"175","author":"AD Voronova","year":"2023","unstructured":"Voronova AD, Karsuntseva EK, Stepanova OV, et al. Modeling of Alzheimer\u2019s disease to study the efficacy of cell therapy (review). Bull Exp Biol Med. 2023;175(4):524-9. https:\/\/doi.org\/10.1007\/s10517-023-05899-8","journal-title":"Bull Exp Biol Med."},{"issue":"2\u20133","key":"6519_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.diff.2009.06.005","volume":"78","author":"FH Moghadam","year":"2009","unstructured":"Moghadam FH, Alaie H, Karbalaie K, et al. Transplantation of primed or unprimed mouse embryonic stem cellderived neural precursor cells improves cognitive function in Alzheimerian rats. Differentiation. 2009;78(2-3):59-68. https:\/\/doi.org\/10.1016\/j.diff.2009.06.005","journal-title":"Differentiation."},{"issue":"1","key":"6519_CR37","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s40478-022-01417-5","volume":"10","author":"E Baerends","year":"2022","unstructured":"Baerends E, Soud K, Folke J, et al. Modeling the early stages of Alzheimer\u2019s disease by administering intracerebroventricular injections of human native A\u03b2 oligomers to rats. Acta Neuropathol Commun. 2022;10(1):113. https:\/\/doi.org\/10.1186\/s40478-022-01417-5","journal-title":"Acta Neuropathol Commun."},{"issue":"5","key":"6519_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/mmr.2022.12699","volume":"25","author":"L Huang","year":"2022","unstructured":"Huang L, Xiao D, Sun H, et al. Behavioral tests for evaluating the characteristics of brain diseases in rodent models: Optimal choices for improved outcomes (Review). Mol Med Rep. 2022;25(5):183. https:\/\/doi.org\/10.3892\/mmr.2022.12699","journal-title":"Mol Med Rep."},{"issue":"1","key":"6519_CR39","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s10517-023-05823-0","volume":"175","author":"EK Karsuntseva","year":"2023","unstructured":"Karsuntseva EK, Voronova AD, Chadin AV, et al. Application of behavioral tests for evaluation of an experimental model of Alzheimer\u2019s disease in femalerats. Bull Exp Biol Med. 2023;175(1):126-31. https:\/\/doi.org\/10.1007\/s10517-023-05823-0","journal-title":"Bull Exp Biol Med."},{"issue":"1","key":"6519_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ame2.12207","volume":"5","author":"C Qin","year":"2022","unstructured":"Qin C, Wang K, Zhang L, et al. Stem cell therapy for Alzheimer\u2019s disease: An overview of experimental models and reality. Animal Model Exp Med. 2022;5(1):15-26. https:\/\/doi.org\/10.1002\/ame2.12207","journal-title":"Animal Model Exp Med."},{"issue":"1","key":"6519_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12864-015-1262-5","volume":"16","author":"AM Hossini","year":"2015","unstructured":"Hossini AM, Megges M, Prigione A, et al. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer\u2019s disease donor as a model for investigating AD-associated gene regulatory networks. BMC Genomics. 2015;16(1):84. https:\/\/doi.org\/10.1186\/s12864-015-1262-5","journal-title":"BMC Genomics."},{"issue":"5","key":"6519_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nbt.2565","volume":"31","author":"Y Liu","year":"2013","unstructured":"Liu Y, Weick JP, Liu H, et al. Medial ganglionic eminencelike cells derived from human embryonic stem cells correct learning and memory deficits. Nat Biotechnol. 2013;31(5):440-7. https:\/\/doi.org\/10.1038\/nbt.2565","journal-title":"Nat Biotechnol."},{"issue":"45","key":"6519_CR43","doi-asserted-by":"publisher","first-page":"19150","DOI":"10.1073\/pnas.0909293106","volume":"106","author":"MM Acharya","year":"2009","unstructured":"Acharya MM, Christie LA, Lan ML, et al. Rescue of radiation-induced cognitive impairment through cranial transplantation of human embryonic stem cells. Proc Natl Acad Sci. USA. 2009;106(45):19150-5. https:\/\/doi.org\/10.1073\/pnas.0909293106","journal-title":"Proc Natl Acad Sci. USA"},{"issue":"1","key":"6519_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis J, Cai H, Shi Y. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal Transduct Target Ther. 2024;9(1):112. https:\/\/doi.org\/10.1038\/s41392-024-01809-0","journal-title":"Signal Transduct Target Ther."},{"issue":"Pt B","key":"6519_CR45","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neulet.2013.10.043","volume":"557","author":"N Fujiwara","year":"2013","unstructured":"Fujiwara N, Shimizu J, Takai K, et al. Restoration of spatial memory dysfunction of human APP transgenic mice by transplantation of neuronal precursors derived from human iPS cells. Neurosci Lett. 2013;557(Pt B):129-34.","journal-title":"Neurosci Lett."},{"key":"6519_CR46","doi-asserted-by":"publisher","unstructured":"Takamatsu K, Ikeda T, Haruta M, et al. Degradation of amyloid beta by human induced pluripotent stem cellderived macrophages expressing Neprilysin-2. Stem Cell Res. 2014;13(3, Pt A):442-53. https:\/\/doi.org\/10.1016\/j.scr.2014.10.001","DOI":"10.1016\/j.scr.2014.10.001"},{"issue":"10","key":"6519_CR47","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s41419-018-0990-2","volume":"9","author":"J Rosati","year":"2018","unstructured":"Rosati J, Ferrari D, Altieri F, et al. Establishment of stableiPS-derived human neural stem cell lines suitablefor cell therapies. Cell Death Dis. 2018;9(10):937. https:\/\/doi.org\/10.1038\/s41419-018-0990-2","journal-title":"Cell Death Dis."},{"issue":"3","key":"6519_CR48","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.3892\/mmr.2020.10918","volume":"21","author":"Q Zhu","year":"2020","unstructured":"Zhu Q, Zhang N, Hu N, et al. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein\/presenilin 1 transgenic mouse model of Alzheimer\u2019s disease. Mol Med Rep. 2020;21(3):1172-80. https:\/\/doi.org\/10.3892\/mmr.2020.10918","journal-title":"Mol Med Rep."},{"issue":"4","key":"6519_CR49","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/jnc.13413","volume":"136","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Wu HH, Wang Y, et al. Neural stem cell transplantation decreases neuroinflammation in a transgenic mouse model of Alzheimer\u2019s disease. J Neurochem. 2016;136(4):815-25. https:\/\/doi.org\/10.1111\/jnc.13413","journal-title":"J Neurochem."},{"issue":"1","key":"6519_CR50","doi-asserted-by":"publisher","first-page":"14776","DOI":"10.1038\/s41598-018-33017-6","volume":"8","author":"LM McGinley","year":"2018","unstructured":"McGinley LM, Kashlan ON, Bruno ES, et al. Human neural stem cell transplantation improves cognition in a murine model of Alzheimer\u2019s disease. Sci Rep. 2018;8(1):14776. https:\/\/doi.org\/10.1038\/s41598-018-33017-6","journal-title":"Sci Rep."},{"issue":"7","key":"6519_CR51","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/hipo.22405","volume":"25","author":"RR Ager","year":"2015","unstructured":"Ager RR, Davis JL, Agazaryan A, et al. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer\u2019s disease and neuronal loss. Hippocampus. 2015;25(7):813-26. https:\/\/doi.org\/10.1002\/hipo.22405","journal-title":"Hippocampus."},{"issue":"2","key":"6519_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.stemcr.2016.12.019","volume":"8","author":"SE Marsh","year":"2017","unstructured":"Marsh SE, Yeung ST, Torres M, et al. HuCNS-SC human NSCs fail to differentiate, form ectopic clusters, and provide no cognitive benefits in a transgenic model of Alzheimer\u2019s disease. Stem Cell Reports. 2017;8(2):235-48. https:\/\/doi.org\/10.1016\/j.stemcr.2016.12.019","journal-title":"Stem Cell Reports."},{"key":"6519_CR53","doi-asserted-by":"publisher","first-page":"7834421","DOI":"10.1155\/2021\/7834421","volume":"2021","author":"AE Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez AE, Garc\u00eda E. Mesenchymal stem cell therapy for Alzheimer\u2019s disease. Stem Cells Int. 2021;2021:7834421. https:\/\/doi.org\/10.1155\/2021\/7834421","journal-title":"Stem Cells Int."},{"issue":"1","key":"6519_CR54","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41598-017-18542-0","volume":"8","author":"DH Kim","year":"2018","unstructured":"Kim DH, Lim H, Lee D, et al. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer\u2019s disease model. Sci Rep. 2018;8(1):354. https:\/\/doi.org\/10.1038\/s41598-017-18542-0","journal-title":"Sci Rep."},{"issue":"Suppl 1","key":"6519_CR55","doi-asserted-by":"publisher","first-page":"S113","DOI":"10.3727\/096368913X672181","volume":"22","author":"T Ma","year":"2013","unstructured":"Ma T, Gong K, Ao Q, et al. Intracerebral transplantation of adipose-derived mesenchymal stem cells alternatively activates microglia and ameliorates neuropathological deficits in Alzheimer\u2019s disease mice. Cell Transplant. 2013;22(Suppl 1):S113-S126. https:\/\/doi.org\/10.3727\/096368913X672181","journal-title":"Cell Transplant."},{"key":"6519_CR56","doi-asserted-by":"publisher","unstructured":"Kim S, Chang KA, Kim Ja, et al. The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer\u2019s disease mice. PLoS One. 2012;7(9):e45757. https:\/\/doi.org\/10.1371\/journal.pone.0045757","DOI":"10.1371\/journal.pone.0045757"},{"key":"6519_CR57","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/632902","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee S, Choi E, Cha MJ, et al. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy. Oxid Med Cell Longev. 2015;2015:632902. https:\/\/doi.org\/10.1155\/2015\/632902","journal-title":"Oxid Med Cell Longev."},{"issue":"12","key":"6519_CR58","doi-asserted-by":"publisher","first-page":"7323","DOI":"10.1007\/s12035-022-03044-6","volume":"59","author":"CG Hong","year":"2022","unstructured":"Hong CG, Chen ML, Duan R, et al. Transplantation of nasal olfactory mucosa mesenchymal stem cells benefits Alzheimer\u2019s disease. Mol Neurobiol. 2022;59(12):7323-36. https:\/\/doi.org\/10.1007\/s12035-022-03044-6","journal-title":"Mol Neurobiol."},{"issue":"3","key":"6519_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.141","volume":"5","author":"K Borgmann-Winter","year":"2015","unstructured":"Borgmann-Winter K, Willard SL, Sinclair D, et al. Translational potential of olfactory mucosa for the study of neuropsychiatric illness. Transl Psychiatry. 2015;5(3):e527. https:\/\/doi.org\/10.1038\/tp.2014.141","journal-title":"Transl Psychiatry."},{"issue":"2","key":"6519_CR60","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4193\/Rhino15.365","volume":"54","author":"PJ Andrews","year":"2016","unstructured":"Andrews PJ, Poirrier AL, Lund VJ, et al. Safety of human olfactory mucosal biopsy for the purpose of olfactory ensheathing cell harvest and nerve repair: a prospective controlled study in patients undergoing endoscopic sinus surgery. Rhinology. 2016;54(2):183-91. https:\/\/doi.org\/10.4193\/Rhino15.365","journal-title":"Rhinology."},{"issue":"3","key":"6519_CR61","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1515\/revneuro-2014-0065","volume":"26","author":"D Duan","year":"2015","unstructured":"Duan D, Lu M. Olfactory mucosa: a rich source of cell therapy for central nervous system repair. Rev Neurosci. 2015;26(3):281-93. https:\/\/doi.org\/10.1515\/revneuro-2014-0065","journal-title":"Rev Neurosci."},{"issue":"4","key":"6519_CR62","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.stemcr.2019.02.014","volume":"12","author":"J Peterson","year":"2019","unstructured":"Peterson J, Lin B, Barrios-Camacho CM, et al. Activating a reserve neural stem cell population in vitro enables engraftment and multipotency after transplantation. Stem Cell Reports. 2019;12(4):680-95. https:\/\/doi.org\/10.1016\/j.stemcr.2019.02.014","journal-title":"Stem Cell Reports."},{"issue":"9","key":"6519_CR63","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/iub.2822","volume":"76","author":"T Ertem","year":"2024","unstructured":"Ertem T, Uysal O. Differentiation of neural stem cells from human olfactory mucosa into dopaminergic neuron-like cells. IUBMB Life. 2024;76(9):697-711. https:\/\/doi.org\/10.1002\/iub.2822","journal-title":"IUBMB Life."},{"key":"6519_CR64","doi-asserted-by":"publisher","unstructured":"Moriwaki T, Iwatsuki K, Mochizuki-Oda N, et al. Presence of trans-synaptic neurons derived from olfactory mucosa transplanted after spinal cord injury. Spine (Phila Pa 1976). 2014;39(16):1267-73. https:\/\/doi.org\/10.1097\/BRS.0000000000000386","DOI":"10.1097\/BRS.0000000000000386"},{"key":"6519_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148764","volume":"1828","author":"B Valipour","year":"2024","unstructured":"Valipour B, Simorgh S, Mirsalehi M, et al. Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer\u2019s disease rat model. Brain Res. 2024;1828:148764. https:\/\/doi.org\/10.1016\/j.brainres.2024.148764","journal-title":"Brain Res."},{"issue":"3","key":"6519_CR66","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/cne.23694","volume":"523","author":"L Nazareth","year":"2015","unstructured":"Nazareth L, Lineburg KE, Chuah MI, et al. Olfactory ensheathing cells are the main phagocytic cells that remove axon debris during early development of the olfactory system. J Comp Neurol. 2015;523(3):479-94. https:\/\/doi.org\/10.1002\/cne.23694","journal-title":"J Comp Neurol."},{"key":"6519_CR67","doi-asserted-by":"publisher","first-page":"963689722112568","DOI":"10.1177\/09636897221125685","volume":"31","author":"M Murtaza","year":"2022","unstructured":"Murtaza M, Mohanty L, Ekberg JAK, et al. Designing olfactory ensheathing cell transplantation therapies: influence of cell microenvironment. Cell Transplant. 2022;31:9636897221125685. https:\/\/doi.org\/10.1177\/09636897221125685","journal-title":"Cell Transplant."},{"key":"6519_CR68","doi-asserted-by":"publisher","unstructured":"Karsuntseva EK, Voronova AD, Stepanova OV, et al. Prospects for the use of olfactory ensheathing cells in the treatment of experimental Alzheimer\u2019s disease. Biotehnologi\u00e2 (Moskva). Russian. https:\/\/doi.org\/10.56304\/S0234275823020047","DOI":"10.56304\/S0234275823020047"},{"issue":"1","key":"6519_CR69","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10517-024-06293-8","volume":"178","author":"EK Karsuntseva","year":"2024","unstructured":"Karsuntseva EK, Voronova AD, Andretsova SS, et al. The effect of transplantation of ensheathing cells of the olfactory mucosa into the hippocampal area on the restoration of cognitive abilities in rats with experimental Alzheimer\u2019s disease. Bull Exp Biol Med. 2024;178(1):115-21. https:\/\/doi.org\/10.1007\/s10517-024-06293-8","journal-title":"Bull Exp Biol Med."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06519-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-025-06519-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-025-06519-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T00:05:09Z","timestamp":1763251509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-025-06519-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6519"],"URL":"https:\/\/doi.org\/10.1007\/s10517-025-06519-3","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"type":"print","value":"0007-4888"},{"type":"electronic","value":"1573-8221"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}